Aseptix develops, patents and markets novel antimicrobial and disinfection technologies. These technologies are licensed out to global market leaders across various industries, ranging from professional (healthcare, food, leisure, beverages, institutional, etc.) to consumer (household) and personal care. The technologies differentiate against traditional antimicrobials by combining fast anti-microbial activity and low-tox profile, with high user-safety.
We have an ambitious approach to eradicate environmentally burdening and user-unsafe antimicrobials, while delivering technologies that can help make our world safer, by lowering infection risks, and reducing outbreaks.
We drive our industry to improved safety and sustainability
Aseptix is on a continuous quest to improve safety and sustainability. Safety by eradicating resistant and pathogenic organisms, avoiding infections to spread, but also safety in use for patients, users and consumers. We are committed to provide an alternative to unsafe and burdening chemicals that are the standard in our industry. We focus on sustainable solutions and sustainable delivery mechanisms to improve quality of living for generations to come.
We move the bar and set a new standard in safer infection control.
The Aseptix mission is to be a trusted innovation partner for our clients in antimicrobial technologies. We prove that fighting microbes does not mean unnecessarily burdening our planet or future generations. We strive to be a global leader in next generation “worry free” antimicrobials for consumers and professionals, excelling in quality, safety and performance.
To become the global alternative replacing user unsafe and environmentally burdening antimicrobials. To enable a world in which future sustainability and current protection against microbes are well balanced.